(Q31024441)

28 June 2017

1 reference

title

Amyloid imaging: from benchtop to bedside (English)

1 reference

28 June 2017

0 references

Chunying Wu

1

1 reference

PubMed ID

16338342

28 June 2017

Victor W Pike

series ordinal

2

1 reference

PubMed ID

16338342

28 June 2017

Yanming Wang

series ordinal

3

1 reference

28 June 2017

1 January 2005

1 reference

Current Topics in Developmental Biology

28 June 2017

1 reference

28 June 2017

70

1 reference

28 June 2017

171-213

1 reference

Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Development and in vitro characterization of a cationized monoclonal antibody against beta A4 protein: a potential probe for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Noninvasive strategies to image cardiovascular apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

PET imaging of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

In vivo molecular-genetic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

The specificity of the staining of amyloid deposits with thioflavine T

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Fundamentals of positron emission tomography and applications in preclinical drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Alzheimer's disease. A firm base for drug development.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

The use of PET and knockout mice in the drug discovery process

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Functional imaging of intratumoral hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Development of an anti-A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Assays for noninvasive imaging of reporter gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Neuropharmacology and drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

PET for in vivo pharmacokinetic and pharmacodynamic measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

An 'anatomical cascade hypothesis' for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Visualization of multidrug resistance in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Noninvasive imaging of reporter gene expression in living subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Amyloidosis: new strategies for treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

The relationship between D 2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Education and the prevalence of dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Synthesis of fluorine-18 labeled GABA uptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Iodinated tracers for imaging amyloid plaques in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Novel stilbenes as probes for amyloid plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Abeta(1-40) peptide radiopharmaceuticals for brain amyloid imaging: (111)In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Abeta peptide radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

[18] Quantification of β-sheet amyloid fibril structures with thioflavin T

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

In situ scanning-tunneling-microscopy studies of early-stage electromigration in Ag

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Scintigraphy with 123I-serum amyloid P component in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Noninvasive imaging of peripherally injected Alzheimer's disease type synthetic A beta amyloid in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Annexin-V imaging for noninvasive detection of cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

For: Is LSO the future of PET?

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

The aging of the human species

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Benzofuran derivatives as Abeta-aggregate-specific imaging agents for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Mutant genes in familial Alzheimer's disease and transgenic models

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Diagnostic criteria for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Alzheimer vaccine: amyloid-beta on trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

beta-peptide immunization: a possible new treatment for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Alzheimer's disease is a synaptic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

In vivo labeling of amyloid with BF-108.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Labeling of cerebral amyloid in vivo with a monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Introduction to PET imaging with emphasis on biomedical research

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

PET practice in nuclear pharmacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Synthesis and11C-labelling of (E,E)-1-(3?,4?-dihydroxystyryl)-4-(3?-methoxy-4?-hydroxystyryl) benzene for PET imaging of amyloid deposits?

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Targeting alzheimer amyloid plaques in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2970008-9

7 January 2021

10.1016/S0070-2153(05)70008-9

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

16338342